arrow
C

Chiara Corti

Harvard University
H指数:29
被引数:3,103

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study☆

Prosigna检测试剂盒对早期HR阳性/HER2阴性乳腺癌患者新辅助治疗决策的影响:一项单中心前瞻性观察研究☆

2025-07-250
OAAI
Machine Learning-Enabled Pathological Features of Post-Preoperative Therapy Surgical Specimens Improves Recurrence Prediction in Patients with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NAC)
2025-03-010
PRE
Results of a prospective observational study evaluating the impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR+/HER2-breast cancer
2024-05-020
PRE
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors

外周血淋巴细胞预测接受CDK4/6抑制剂治疗的激素受体阳性HER2-negative晚期乳腺癌患者的临床结局

2023-12-201
OAAI
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
2023-12-010
PRE
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
2023-11-012
PRE
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
2023-04-1715
OAAI